STEVENS CAPITAL MANAGEMENT LP - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 86 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$50,000
-67.3%
13,023
-42.8%
0.00%
-60.0%
Q4 2014$153,000
+159.3%
22,781
+112.4%
0.01%
+150.0%
Q3 2014$59,000
-62.2%
10,723
-29.4%
0.00%
-50.0%
Q2 2014$156,000
+5.4%
15,193
+16.4%
0.00%0.0%
Q4 2013$148,000
-8.6%
13,052
-13.2%
0.00%
-20.0%
Q3 2013$162,00015,0350.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 62,000$216,0000.20%
Monashee Investment Management LLC 187,190$651,0000.15%
Cedar Wealth Management, LLC 46,395$161,0000.10%
BCWM, LLC 35,100$122,0000.06%
Tibra Equities Europe Ltd 149,595$521,0000.05%
Ahrens Investment Partners LLC 30,900$108,0000.05%
ExodusPoint Capital Management, LP 151,904$529,0000.04%
Laurion Capital Management LP 833,400$2,900,0000.04%
Alpine Global Management, LLC 33,928$118,0000.03%
Cornerstone Capital, Inc. 57,550$200,0000.03%
View complete list of ACELRX PHARMACEUTICALS INC shareholders